Its clinical stage products include envafolimab (KN035), a PD-L1 single-domain antibody for the treatment of refractory soft tissue sarcoma; and YH001, an investigational humanized cytotoxic ...

Researchers are developing the world’s first topical cream to prevent and treat skin cancer, especially for organ transplant ...

Pembrolizumab is under clinical development by Merck and currently in Phase II for Anal Cancer. According to GlobalData, Phase II drugs for Anal Cancer have a 19% phase transition success rate (PTSR) ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for Soft Tissue Sarcoma. According to GlobalData, Phase II drugs for Soft Tissue Sarcoma have a 26% phase transition success ...

In May 2024, IsoPet ® was launched as a standalone division within Vivos Inc., reaffirming the company's commitment to ...

"Every cancer has a flower—my cancer is a sunflower. The sunflower is the only flower that can grow 6 feet tall. It is resilient," the mom said.

These survivors, or “cancer thrivers” as some of us prefer to say, helped show me that metastatic cancer is no longer a death sentence.

Vivos Inc. (OTCQB: RDGL) proudly announces the initiation of its first human clinical trial for RadioGel® Precision Radionuclide Therapy in India. This ...

Vivos Inc. (OTCQB: RDGL) proudly announces the initiation of its first human clinical trial for RadioGel® Precision Radionuclide Therapy™ in India. This milestone trial, which has commenced with the ...

Researchers compared QOL and other outcomes between patients with endometrial cancer who took short-course adjuvant VCB and ...

Four oncologists from the Sarah Cannon Research Institute in Tennessee shared with Fox News Digital what they see as the most ...

Panelists discuss how, coming into ASH 2024, the largest unmet needs in the treatment and management of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) include improving outcomes ...